Casale et al., in an exploratory analysis of clinical trials of tiotropium for asthma, reported that the clinical benefit of tiotropium was independent of the T2 phenotype, as it was stated by total IgE and blood eosinophils levels [57]. The gene discussed is IGHE; the disease is asthma.